198 related articles for article (PubMed ID: 30443171)
21. Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest.
Sarin N; Engel F; Kalayda GV; Mannewitz M; Cinatl J; Rothweiler F; Michaelis M; Saafan H; Ritter CA; Jaehde U; Frötschl R
PLoS One; 2017; 12(7):e0181081. PubMed ID: 28746345
[TBL] [Abstract][Full Text] [Related]
22. Adenylate kinase-4 is a marker of poor clinical outcomes that promotes metastasis of lung cancer by downregulating the transcription factor ATF3.
Jan YH; Tsai HY; Yang CJ; Huang MS; Yang YF; Lai TC; Lee CH; Jeng YM; Huang CY; Su JL; Chuang YJ; Hsiao M
Cancer Res; 2012 Oct; 72(19):5119-29. PubMed ID: 23002211
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of NDRG1 predicts poor outcome and facilitates disease progression by influencing the EMT process in bladder cancer.
Li A; Zhu X; Wang C; Yang S; Qiao Y; Qiao R; Zhang J
Sci Rep; 2019 Mar; 9(1):5166. PubMed ID: 30914736
[TBL] [Abstract][Full Text] [Related]
24. N-myc downstream regulated gene1/Cap43 overexpression suppresses tumor growth by hepatic cancer cells through cell cycle arrest at the G0/G1 phase.
Akiba J; Murakami Y; Noda M; Watari K; Ogasawara S; Yoshida T; Kawahara A; Sanada S; Yasumoto M; Yamaguchi R; Kage M; Kuwano M; Ono M; Yano H
Cancer Lett; 2011 Nov; 310(1):25-34. PubMed ID: 21775055
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia and retinoic acid-inducible NDRG1 expression is responsible for doxorubicin and retinoic acid resistance in hepatocellular carcinoma cells.
Jung EU; Yoon JH; Lee YJ; Lee JH; Kim BH; Yu SJ; Myung SJ; Kim YJ; Lee HS
Cancer Lett; 2010 Dec; 298(1):9-15. PubMed ID: 20573444
[TBL] [Abstract][Full Text] [Related]
26. Effect of miR-1244 on cisplatin-treated non-small cell lung cancer via MEF2D expression.
Li GJ; Zhao GQ; Yang JP; Zhou YC; Yang KY; Lei YJ; Huang YC
Oncol Rep; 2017 Jun; 37(6):3475-3483. PubMed ID: 28498474
[TBL] [Abstract][Full Text] [Related]
27. Golgi Phosphoprotein 3 Inhibits the Apoptosis of Human Glioma Cells in Part by Downregulating N-myc Downstream Regulated Gene 1.
Li X; Li M; Tian X; Li Q; Lu Q; Jia Q; Zhang L; Yan J; Li X; Li X
Med Sci Monit; 2016 Oct; 22():3535-3543. PubMed ID: 27698340
[TBL] [Abstract][Full Text] [Related]
28. SET-mediated NDRG1 inhibition is involved in acquisition of epithelial-to-mesenchymal transition phenotype and cisplatin resistance in human lung cancer cell.
Liu H; Gu Y; Yin J; Zheng G; Wang C; Zhang Z; Deng M; Liu J; Jia X; He Z
Cell Signal; 2014 Dec; 26(12):2710-20. PubMed ID: 25152373
[TBL] [Abstract][Full Text] [Related]
29. NDRG1/Cap43 overexpression in tumor tissues and serum from lung cancer patients.
Wang D; Tian X; Jiang Y
J Cancer Res Clin Oncol; 2012 Nov; 138(11):1813-20. PubMed ID: 22722710
[TBL] [Abstract][Full Text] [Related]
30. NDRG1 links p53 with proliferation-mediated centrosome homeostasis and genome stability.
Croessmann S; Wong HY; Zabransky DJ; Chu D; Mendonca J; Sharma A; Mohseni M; Rosen DM; Scharpf RB; Cidado J; Cochran RL; Parsons HA; Dalton WB; Erlanger B; Button B; Cravero K; Kyker-Snowman K; Beaver JA; Kachhap S; Hurley PJ; Lauring J; Park BH
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):11583-8. PubMed ID: 26324937
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of the N-myc downstream regulated gene 1 is related to enhanced proliferation, invasion and migration of pancreatic cancer.
Cen G; Zhang K; Cao J; Qiu Z
Oncol Rep; 2017 Feb; 37(2):1189-1195. PubMed ID: 28075464
[TBL] [Abstract][Full Text] [Related]
32. Activating transcription factor 3 promotes malignance of lung cancer cells in vitro.
Li X; Zhou X; Li Y; Zu L; Pan H; Liu B; Shen W; Fan Y; Zhou Q
Thorac Cancer; 2017 May; 8(3):181-191. PubMed ID: 28239957
[TBL] [Abstract][Full Text] [Related]
33. NDRG1 inhibition sensitizes osteosarcoma cells to combretastatin A-4 through targeting autophagy.
Wang H; Li W; Xu J; Zhang T; Zuo D; Zhou Z; Lin B; Wang G; Wang Z; Sun W; Sun M; Chang S; Cai Z; Hua Y
Cell Death Dis; 2017 Sep; 8(9):e3048. PubMed ID: 28906492
[TBL] [Abstract][Full Text] [Related]
34. N-myc downstream regulated gene 1 acts as a tumor suppressor in ovarian cancer.
Wang B; Li J; Ye Z; Li Z; Wu X
Oncol Rep; 2014 May; 31(5):2279-85. PubMed ID: 24626771
[TBL] [Abstract][Full Text] [Related]
35. [Mechanism of thymosin beta 10 inhibiting the apoptosis
and prompting proliferation in A549 cells].
Li Z; Qu L; Zhong H; Xu K; Qiu X
Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):783-8. PubMed ID: 25404268
[TBL] [Abstract][Full Text] [Related]
36. Induction of apoptosis by pyrazolo[3,4-d]pyridazine derivative in lung cancer cells via disruption of Bcl-2/Bax expression balance.
Mohamed MS; Abdelhamid AO; Almutairi FM; Ali AG; Bishr MK
Bioorg Med Chem; 2018 Feb; 26(3):623-629. PubMed ID: 29290491
[TBL] [Abstract][Full Text] [Related]
37. Association of NDRG1 gene promoter methylation with reduced NDRG1 expression in gastric cancer cells and tissue specimens.
Chang X; Zhang S; Ma J; Li Z; Zhi Y; Chen J; Lu Y; Dai D
Cell Biochem Biophys; 2013 May; 66(1):93-101. PubMed ID: 23099645
[TBL] [Abstract][Full Text] [Related]
38. TAB3 overexpression promotes cell proliferation in non-small cell lung cancer and mediates chemoresistance to CDDP in A549 cells via the NF-κB pathway.
Chen J; Gu J; Feng J; Liu Y; Xue Q; Ni T; Wang Z; Jia L; Mao G; Ji L
Tumour Biol; 2016 Mar; 37(3):3851-61. PubMed ID: 26476534
[TBL] [Abstract][Full Text] [Related]
39. NDRG1 promotes the multidrug resistance of neuroblastoma cells with upregulated expression of drug resistant proteins.
Zhang D; Jia J; Zhao G; Yue M; Yang H; Wang J
Biomed Pharmacother; 2015 Dec; 76():46-51. PubMed ID: 26653549
[TBL] [Abstract][Full Text] [Related]
40. The iron-regulated metastasis suppressor NDRG1 targets NEDD4L, PTEN, and SMAD4 and inhibits the PI3K and Ras signaling pathways.
Kovacevic Z; Chikhani S; Lui GY; Sivagurunathan S; Richardson DR
Antioxid Redox Signal; 2013 Mar; 18(8):874-87. PubMed ID: 22462691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
